CD4 and neoplasm: As whole tumor lysates provide the full repertoire of characterized and uncharacterized tumor-associated antigens for both CD4+ and CD8+ T cells, this allows for parallel presentation of antigens to both T cell types to generate stronger primary immune responses and to prevent the emergence of tumor escape variants.